Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Analysis of Methemoglobin as a Biomarker of Tissue Hypoxia During Acute Hemodilutional Anemia in Patients Undergoing Heart Surgery

NCT01883713 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT01883713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01883713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Analysis of Methemoglobin as a Biomarker of Tissue Hypoxia During Acute Hemodilutional Anemia in Patients Undergoing Heart Surgery
Lead sponsor
Unity Health Toronto
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
August 31, 2016
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

other functional disturbances following cardiac surgery